Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Dec 27;11(6):e114623.
doi: 10.5812/aapm.114623. eCollection 2021 Dec.

Comparison of Intraperitoneal Bupivacaine and Intravenous Ketorolac for Postoperative Pain Management Following Laparoscopic Cholecystectomy

Affiliations

Comparison of Intraperitoneal Bupivacaine and Intravenous Ketorolac for Postoperative Pain Management Following Laparoscopic Cholecystectomy

AmirAhmad Arabzadeh et al. Anesth Pain Med. .

Abstract

Background: Postoperative pain following laparoscopic cholecystectomy (LC) arises from incision sites and residual intraperitoneal CO2 gas. Opioids as a class of pain-relieving drugs are broadly used to control pain after LC; however, these drugs can cause various side effects.

Objectives: The purpose of this study was to compare the efficacy of intraperitoneal injection of bupivacaine with that of intravenous ketorolac in managing postoperative pain in patients who had undergone LC.

Methods: This randomized, double-blind clinical trial was carried out on patients who had undergone LC. Ninety patients who had undergone elective LC were randomly divided into 3 groups (n = 30 for each group). Group A received 40 mL of 0.25% bupivacaine solution intraperitoneally at the end of the operation; group B received 30 mg of ketorolac intravenously 30 minutes before surgery and every 8 hours after surgery, and patients in group C received normal saline intraperitoneally and intravenous injection. The patients were postoperatively assessed for Visual Analog Scale (VAS) scores, postoperative opioid consumption, shoulder pain, side effects (sedation, nausea, and vomiting), and satisfaction. The data were analyzed using SPSS. P values < 0.05 were considered significant.

Results: The intraperitoneal injection of bupivacaine and intravenous injection of ketorolac were significantly effective in reducing postoperative abdominal pain, shoulder pain, and incidence of nausea and vomiting compared to the placebo group (P < 0.001). Although intraperitoneal bupivacaine and intravenous ketorolac had no significant difference in pain relief compared with each other, patients in both bupivacaine and ketorolac groups were significantly more satisfied with their analgesia compared to the control group (P < 0.001).

Conclusions: Intraperitoneal injection of bupivacaine and intravenous injection of ketorolac both are safe and effective methods to control pain, nausea, and vomiting after LC.

Keywords: Bupivacaine; Intraperitoneal Injection; Ketorolac; Laparoscopic Cholecystectomy; Postoperative Pain.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interests: The authors have declared no conflict of interest.

Figures

Figure 1.
Figure 1.. Flowchart of the study
Figure 2.
Figure 2.. Comparison of the pain scores (Visual Analog Scale) in the experimental groups at postoperative times. Values are represented as mean ± SD. Differences between the results of the placebo group and other groups (*** P < 0.001; n = 30 for each group).
Figure 3.
Figure 3.. Percentage of the nausea incidence in the experimental groups 24 hours after surgery (n = 30 for each group).
Figure 4.
Figure 4.. Comparison of the shoulder pain in the experimental groups at postoperative times. Values are represented as mean ± SD. Differences between the results of the placebo group and other groups (*** P < 0.001; n = 30 for each group).
Figure 5.
Figure 5.. Comparison of the postoperative analgesic consumption in the experimental groups at postoperative times. Values are represented as the number of frequency. Differences between the results of the placebo group and other groups (*** P < 0.001; n = 30 for each group).
Figure 6.
Figure 6.. Patients’ satisfaction with analgesia in the studied groups. Values are represented as mean ± SD (n = 30 for each group).

Similar articles

Cited by

References

    1. Marino MV, Mirabella A, Guarrasi D, Lupo M, Komorowski AL. Robotic-assisted repair of iatrogenic common bile duct injury after laparoscopic cholecystectomy: Surgical technique and outcomes. Int J Med Robot. 2019;15(3):e1992. doi: 10.1002/rcs.1992. - DOI - PubMed
    1. Ghomeishi A, Mohtadi AR, Behaeen K, Nesioonpour S, Bakhtiari N, Khalvati Fahlyani F. Comparison of the Effect of Propofol and Dexmedetomidine on Hemodynamic Parameters and Stress Response Hormones During Laparoscopic Cholecystectomy Surgery. Anesth Pain Med. 2021;11(5):e119446. doi: 10.5812/aapm.119446. - DOI - PMC - PubMed
    1. Norozi V, Ghazi A, Amani F, Bakhshpoori P. Effectiveness of Sublingual Buprenorphine and Fentanyl Pump in Controlling Pain After Open Cholecystectomy. Anesth Pain Med. 2021;11(3):e113909. doi: 10.5812/aapm.113909. - DOI - PMC - PubMed
    1. Aditianingsih D, Mochtar CA, Chandra S, Sukmono RB, Soamole IW. Comparison of Three-Quadrant Transversus Abdominis Plane Block and Continuous Epidural Block for Postoperative Analgesia After Transperitoneal Laparoscopic Nephrectomy. Anesth Pain Med. 2018;8(5):e80024. doi: 10.5812/aapm.80024. - DOI - PMC - PubMed
    1. Davari-Tanha F, Samimi S, Khalaj Z, Bastanhagh E. Comparison of Intraperitoneal Normal Saline Infusion with Pulmonary Recruitment Maneuver in Reducing Shoulder and Upper Abdomen Pain Following Gynecologic Laparoscopic Procedures: A Randomized, Controlled, Triple-Blind Trial. Anesth Pain Med. 2019;9(3):e92444. doi: 10.5812/aapm.92444. - DOI - PMC - PubMed

LinkOut - more resources